A protein called LENG8 traps defective RNA molecules inside the cell nucleus before they can reach the cytoplasm and disrupt normal cellular function, according to a study published in Molecular Cell on March 19, 2026. Researchers at the University of California, Irvine identified LENG8 as the long-sought “gatekeeper” that monitors whether RNA has been properly processed, then blocks export of any transcripts that fail inspection. The finding resolves a question that has persisted in molecular biology for decades: how do cells distinguish between correctly assembled messenger RNA and faulty copies?
A Three-Decade Search for the Missing Factor
Cells constantly produce messenger RNA (mRNA) from DNA templates, but not every transcript comes out right. Splicing errors, incomplete processing, and other defects can generate aberrant mRNAs and noncoding RNAs that, if allowed into the cytoplasm, could produce toxic proteins or interfere with gene regulation. Scientists have known since the early 1990s that eukaryotic cells retain these problematic transcripts inside the nucleus, yet the identity of the factor responsible for that retention remained unclear for more than 30 years.
The problem was not simply academic. Proper mRNA processing is essential for the maintenance of cellular and tissue homeostasis, and breakdowns in that quality control have been linked to diseases ranging from cancers to neurodegeneration. Without knowing which molecule enforced nuclear retention, researchers lacked a clear target for understanding or treating those breakdowns. As the UC Irvine team later emphasized in a university release, the basic mechanisms that determine which RNAs are allowed to exit the nucleus “have long remained a mystery.”
How LENG8 Blocks Faulty RNA Export
The UC Irvine group used genome-wide CRISPR screening to systematically knock out genes and observe which losses allowed defective RNA to escape the nucleus. This unbiased approach, described in detail in the Molecular Cell report, singled out LENG8 as a conserved protein acting early in the RNA lifecycle. LENG8 is recruited to nascent transcripts through the U1 small nuclear ribonucleoprotein (U1 snRNP), a core component of the early splicing machinery. Because this recruitment happens while RNA is still being assembled, LENG8 effectively gains a first look at whether splicing and processing are proceeding correctly.
Once bound to a transcript, LENG8 associates with two other proteins, PCID2 and SEM1, to form a three-member assembly the authors term the REX complex. This complex physically interferes with the RNA’s access to the nuclear export channel. At the same time, biochemical experiments showed that LENG8 links defective transcripts to the PAXT pathway, directing them toward degradation by the nuclear RNA exosome. As summarized in the paper’s highlighted findings, LENG8 serves as a key quality-control factor that retains incompletely and aberrantly processed RNAs in the nucleus while promoting their destruction.
What makes this system especially striking is its direct competition with the normal export machinery. In parallel work, structural biologists dissected how the TREX-2 complex collaborates with the helicase UAP56 to drive export of correctly processed mRNA through the nuclear pore. The LENG8 study reports that the REX complex antagonizes this pathway through dominant-negative competition: REX and TREX-2 share overlapping components, so when REX occupies a transcript, it effectively locks out the export apparatus. Only when processing is complete and quality checks are satisfied does LENG8 release its hold, allowing the export factors to engage.
Inside the Experiments
To confirm that LENG8 truly decides which RNAs stay or go, the team combined CRISPR perturbations with high-throughput sequencing. Using genome-wide screening, they first identified LENG8 as the factor whose loss most strongly increased cytoplasmic accumulation of known defective RNAs. That screening workflow, which relied on pooled libraries and fluorescent readouts of RNA localization, is outlined in supplementary figures and builds on earlier HeLa cell assays that mapped protein–RNA interactions in nuclear extracts.
The researchers then turned to RNA sequencing to quantify the consequences of removing LENG8. They prepared whole-cell lysates, cytoplasmic fractions, and nuclear fractions from control cells and from cells in which LENG8 was depleted, and subjected each compartment to deep sequencing. The resulting datasets, deposited under BioProject PRJNA1240595, allowed a transcript-by-transcript comparison of nuclear versus cytoplasmic abundance.
The pattern was unambiguous: in the absence of LENG8, incompletely spliced mRNAs and certain noncoding RNAs that normally remain confined to the nucleus appeared at elevated levels in the cytoplasm. Conversely, properly processed mRNAs showed relatively modest changes. This selectivity supported the idea that LENG8 does not simply slow down bulk export; it discriminates between normal and aberrant transcripts and blocks only the latter. Access to the underlying sequencing files and metadata requires a standard NCBI login, but the published analysis already demonstrates that LENG8 shapes the cytoplasmic transcriptome by enforcing a nuclear checkpoint.
Microscopy and biochemical fractionation further corroborated this model. Fluorescent in situ hybridization revealed that model defective transcripts, which are usually stuck in nuclear foci, redistributed into the cytoplasm when LENG8 was knocked down. Co-immunoprecipitation experiments showed that LENG8 physically associates with U1 snRNP and with components of the PAXT adaptor complex, linking early splice-site recognition to downstream degradation. Together, these lines of evidence position LENG8 at the crossroads of processing, retention, and decay.
Beyond the “Gatekeeper” Metaphor
Early coverage understandably latched onto the image of LENG8 as a gatekeeper. Yet the deeper implication is that cells operate an active checkpoint system, more akin to quality control on a factory floor than to a passive door that opens only when the right badge appears. Before this work, a prevailing idea held that improperly processed RNAs simply lacked the export signals needed to recruit TREX-2 and related factors, and therefore never made it out. The new data flip that narrative: nuclear retention is not merely the absence of a positive signal, but the presence of an active repressor.
This conceptual shift has practical consequences. If retention were purely passive, there would be little to target pharmacologically; one cannot easily drug the absence of a mark. By contrast, an active retention factor such as LENG8, together with its REX partners PCID2 and SEM1, presents defined protein surfaces that could, in principle, be modulated. As the UC Irvine investigators noted in a summary of their CRISPR work, the discovery that a single factor “is granted permission for export” decisions opens the door to targeted manipulation of that decision point.
Potential Links to Disease and Therapy
Although the current study focuses on basic mechanisms, the authors point out that failures in RNA quality control are hallmarks of several human diseases. In some cancers, for example, splicing programs are broadly disrupted, generating large numbers of aberrant transcripts. If LENG8 or its cofactors are impaired in such contexts, defective RNAs might slip into the cytoplasm and be translated into oncogenic proteins or dominant-negative fragments. Conversely, hyperactive retention could starve cells of needed mRNAs, contributing to degenerative conditions.
Therapeutically, one can imagine two broad strategies. In diseases where harmful transcripts escape the nucleus, small molecules or biologics that stabilize LENG8–REX interactions, or enhance recruitment to vulnerable RNAs, might restore the retention-and-destruction pathway. In settings where beneficial RNAs are inappropriately trapped, partial inhibition of LENG8 activity could ease export and rebalance gene expression. Because LENG8 acts upstream of both TREX-2–mediated export and PAXT-mediated decay, interventions at this node might have outsized effects.
Any such applications remain speculative, and the risks of globally altering RNA surveillance are substantial. Still, the identification of a discrete molecular switch that governs the fate of defective transcripts provides a rare point of leverage in an otherwise diffuse network of processing factors. For a field that has spent decades inferring the existence of a nuclear retention system from indirect evidence, finally putting a name and mechanism to that system marks a turning point.
By anchoring nuclear retention in the activity of LENG8 and the REX complex, the new work offers a coherent framework for understanding how cells prevent bad RNA from becoming bad protein. It also illustrates how modern genome-wide tools, combined with classical biochemistry and careful fractionation, can resolve long-standing mysteries in cell biology. The nucleus, it turns out, does not merely tolerate defective transcripts until they decay on their own; it actively sequesters and eliminates them, with LENG8 standing watch at the gate.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
